← All trials
NCT05674864
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2023
- Primary completion
- Aug 1, 2023
- Completion date
- Sep 10, 2023
- First posted
- Jan 9, 2023
- Last posted
- Jan 9, 2023
- Enrollment
- 92
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Tanta UniversityLead sponsor
- Tanta UniversityOverall official - principal investigator
- Tanta UniversityReponsible party - principal investigator
- Tanta UniversityStudy director
- Zagazig UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.